Skip to main content
. 2020 Jun 26;11:3257. doi: 10.1038/s41467-020-16814-4

Table 2.

Adverse events.

Tumor type Dose cohort Adverse event Grade Intervention Resolved
BC 0.3 mg per kg Headache I No Yes
BC 0.3 mg per kg Pain left cheek I No Yes
BC 0.3 mg per kg Flush I No Yes
BC 0.3 mg per kg Dizziness I No Yes

Adverse events that occurred during the course of the study which were possibly related to imaging agent administration and scored according to the Common Terminology Criteria for Adverse Events (CTCAE) v4.03: June 14, 2010.

BC breast cancer.